{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:32:40Z","timestamp":1757611960122,"version":"3.44.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10620-025-09108-6","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:50:07Z","timestamp":1748645407000},"page":"2916-2917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ustekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?"],"prefix":"10.1007","volume":"70","author":[{"given":"Thanaboon","family":"Chaemsupaphan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julajak","family":"Limsrivilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"9108_CR1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands BE, Sandborn WJ, Panaccione R, O\u2019Brien CD, Zhang H, Johanns J et al. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019;381:1201\u20131214.","journal-title":"N Engl J Med."},{"key":"9108_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ibd\/izac275","volume":"30","author":"JP Gisbert","year":"2024","unstructured":"Gisbert JP, Parody-Rua E, Chaparro M. Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review. Inflamm Bowel Dis. 2024;30:292\u2013302.","journal-title":"Inflamm Bowel Dis."},{"key":"9108_CR3","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.cgh.2019.11.059","volume":"18","author":"OJ Adedokun","year":"2020","unstructured":"Adedokun OJ, Xu Z, Marano C, O\u2019Brien C, Szapary P, Zhang H et al. Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020;18:2244\u201355 e9.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9108_CR4","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s10620-023-07822-7","volume":"68","author":"T Straatmijer","year":"2023","unstructured":"Straatmijer T, Biemans VBC, Moes D, Hoentjen F, Ter Heine R, Maljaars PWJ et al. Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn\u2019s Disease. Dig Dis Sci. 2023;68:2647\u20132657.10.1007\/s10620-017-4465-6","journal-title":"Dig Dis Sci."},{"key":"9108_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2468-1253(21)00474-X","volume":"7","author":"S Danese","year":"2022","unstructured":"Danese S, Vermeire S, D\u2019Haens G, Panes J, Dignass A, Magro F et al. Treat to target versus standard of care for patients with Crohn\u2019s disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. Lancet Gastroenterol Hepatol. 2022;7:294\u2013306.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"9108_CR6","doi-asserted-by":"crossref","unstructured":"Schreiber SW, Lee S, van der Woude CJ, Mar\u00edn-Jim\u00e9nez I, Wolf D, Schnoy E, et al. P436 Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn\u2019s disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial. Journal of Crohn\u2019s and Colitis. 2023;17(Supplement_1):i564-i6.","DOI":"10.1093\/ecco-jcc\/jjac190.0566"},{"key":"9108_CR7","doi-asserted-by":"crossref","unstructured":"Bossuyt Md PhD P, Rahier JF, Baert F, Louis E, Macken E, Lobaton T, et al. OP35 Low remission recapture after ustekinumab dose optimization in Crohn\u2019s disease: results of the randomized placebo-controlled double-blind REScUE study. Journal of Crohn's and Colitis. 2025;19(Supplement_1):i69-i70.","DOI":"10.1093\/ecco-jcc\/jjae190.0035"},{"key":"9108_CR8","doi-asserted-by":"crossref","unstructured":"Chaemsupaphan T, Arzivian A, Leong RW. Comprehensive care of ulcerative colitis: new treatment strategies. Expert Rev Gastroenterol Hepatol. 2025.","DOI":"10.1080\/17474124.2025.2457451"},{"key":"9108_CR9","doi-asserted-by":"crossref","unstructured":"van Lierop LMA, Albino L, Rosentreter R, Thomas PWA, Lu C, Siffledeen J, et al. Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study. Dig Dis Sci. 2025.10.1007\/s10620-017-4465-6","DOI":"10.1007\/s10620-025-08977-1"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09108-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:17:25Z","timestamp":1756963045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09108-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9108"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09108-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}